Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Diverticulitis Disease market size evolved in recent years?

The market size for diverticulitis disease has seen significant expansion in the past few years. An increase from $1.85 billion in 2024 to $2.04 billion in 2025 is anticipated, boasting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to the progress in the previous period include the aging population, eating habits, obesity, and enhancements in medical imaging.

What are the predictions for the diverticulitis disease market size in the coming years?

Robust expansion is anticipated in the diverticulitis disease market in the forthcoming years. The market size is projected to escalate to $2.92 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The pronounced growth during the forecast period can be credited to factors such as the rise in colonoscopy and endoscopy, heightened consciousness, less invasive treatments, and personalized medical approach. Preventive steps, improved diagnostic instruments, cooperative healthcare models, and alterations in healthcare policies are key trends expected to shape the market during the forecast period.

Get your diverticulitis disease market report here!

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

What key factors are fueling the growth of the diverticulitis disease market?

Advancements in the diverticulitis disease market are anticipated due to the increasing prevalence of smoking addiction. This addiction, largely promoted by aggressive marketing, societal acceptance, stress, and the addictive characteristics of nicotine, plays a significant role in the market’s expansion. The emergence of e-cigarettes and vaping devices, coupled with social influences and peer pressure among young individuals, heightens smoking rates. Smoking escalates the risk of diverticular disease by weakening the colon’s blood flow, leading to severe complications and a surge in demand for diagnosis and treatment options. For example, in July 2022, Statistics Canada, a governmental agency, reported a 5.8% increase in cigarette production compared to June 2021, while cigarette sales grew by 1.3% from May 2022 to 1.4 billion in June 2022. These trends underline how smoking addiction prevalence can directly influence diverticulitis disease market growth. A noticeable prevalence of diabetes also contributes significantly to the diverticulitis disease market’s progression. Factors such as unhealthy eating habits, a sedentary lifestyle, rampant obesity rates, genetic predispositions, and a growing aged population contribute to diabetes prevalence. This escalates the risk of complications like weakened blood vessels, making the colon more susceptible to infections and inflammations and pushing the demand for treatments and therapies higher. A notable example is NHS England’s report in June 2024 stating that prediabetes cases had risen to 3,615,330 in 2023, marking an 18% increase from 3,065,825 in 2022. Moreover, the under-40 age cohort saw a near 25% growth in diabetes incidences, from 173,166 in 2022 to 216,440 in 2023. Therefore, diabetes prevalence is undoubtedly a key driver of the diverticulitis disease market.

How is the global diverticulitis disease market divided into key segments?

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids

4) By End-User: Specialty Centers, Hospitals, Research centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

Who are the key firms paving the way for growth in the diverticulitis disease market?

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Which trends are expected to transform the diverticulitis disease market?

Leading firms in the diverticulitis disease market are focusing on creating novel drugs and securing their approval in order to maintain their market dominance. Advancing in drug development could establish more efficient therapies for diverticulitis, lessen the probability of complications, and enhance patient prognosis. For example, in April 2023, the US Food and Drug Administration, a federal entity based in the United States, gave its sanction to Seres’ microbiota medication designed to treat recurrent bowel infections and prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and above. The clearance for Vowst came following a clinical trial that included 346 patients with recurrent CDI. The trial concluded that those who received Vowst had a significantly lower chance of experiencing a relapse of the infection compared to those who were given a placebo. This orally-administered drug is built upon microbiota composed of Firmicutes spores, which are recognised for creating a healthy microbiome that can stave off C. diff. colonisation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990

What regions are contributing significantly to the growth of the diverticulitis disease market?

North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Digestive Health Supplements Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/irritable-bowel-syndrome-ibs-treatment-global-market-report

Antacids Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: